Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000669995 | SCV000794803 | uncertain significance | Hyperinsulinemic hypoglycemia, familial, 1 | 2017-10-17 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001175474 | SCV001339054 | uncertain significance | not specified | 2020-03-31 | criteria provided, single submitter | clinical testing | Variant summary: ABCC8 c.4141G>A (p.Gly1381Ser) results in a non-conservative amino acid change located in the ABC transporter-like domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 9.8e-06 in 204398 control chromosomes. c.4141G>A has been reported in the literature in individuals affected with Congenital Hyperinsulinism. One patient had severe persistent hyperinsulinemic hypoglycemia of infancy, with unknown parental origin for this heterozygous variant (Nestrorowicz_1998). A second patient had transient focal type HI, with paternally inherited p.Gly1381Ser and no second allele reported (Christensen_2001). A third patient had diffuse CHI, and the variant was inherited maternally, without a paternal allele reported (Salomon-Estebanez_2016). These data indicate that the variant may be associated with disease. The variant resulted in functional channels, with a reduced response to stimulation by MgADP, which was suggested to result in hyperinsulinism, since the channel will now be less responsive to an increase of intracellular [ADP]:[ATP] as a consequence of low blood glucose level (Shyng_1998). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. |
Natera, |
RCV001830444 | SCV002077505 | uncertain significance | Hereditary hyperinsulinism | 2021-01-15 | no assertion criteria provided | clinical testing |